Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
British American Tobacco $1.7 billion notes offering
The offering is composed of two tranches of notes
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Amer Sports $1.2 billion credit facilities and €700 million credit facility
We advised the borrowers on the financing transactions
Export Development Canada $3.5 billion global bond offering
The investment-grade bonds are due 2029
Cigna $4.5 billion senior notes offering
The senior notes are due 2029, 2031, 2034 and 2054
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Eli Lilly $6.5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064